So Eui-Young, Kim Seol-Hee, Park Hyun-Hee, Cho Byoung-Soo, Lee Choong-Eun
Department of Biological Science and Institute for Basic Science, SungKyunKwan University, 440-746, Suwon, South Korea.
FEBS Lett. 2002 May 8;518(1-3):53-9. doi: 10.1016/s0014-5793(02)02635-2.
Corticosteroids are potent anti-inflammatory and immunosuppressive agents which down-regulate cytokine production and action. Yet, contradictory results have been reported for their effects on the interleukin (IL)-4-mediated response. Using type II Fc receptor for IgE/CD23 as a target gene, here we report that corticosteroids at 10(-4)-10(-6) M inhibit the IL-4 signaling pathway in human primary immune cells by down-regulation of the IL-4-induced IL-4 receptor expression and STAT6 activation. Although functional antagonism between steroid receptor and STAT6 for their transcriptional activity has been recently described, this is the first report that steroid inhibits the IL-4-induced STAT6 activity at the level of tyrosine phosphorylation and target DNA binding.
皮质类固醇是强效的抗炎和免疫抑制剂,可下调细胞因子的产生和作用。然而,关于它们对白细胞介素(IL)-4介导反应的影响,已有相互矛盾的报道。以IgE/CD23的II型Fc受体作为靶基因,我们在此报告,10^(-4)-10^(-6) M的皮质类固醇通过下调IL-4诱导的IL-4受体表达和STAT6激活,抑制人原代免疫细胞中的IL-4信号通路。尽管最近已描述了类固醇受体与STAT6在转录活性方面的功能拮抗作用,但这是首次报道类固醇在酪氨酸磷酸化和靶DNA结合水平上抑制IL-4诱导的STAT6活性。